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Introduction
Pulmonary artery hypertension (PAH) occurs when the resistance of the pulmonary vasculature increases, resulting in chronic elevated afterload and subsequent right ventricle (RV) dysfunction. Available therapies aim to reduce afterload by promoting vasodilation, however there is no cure and novel treatments are needed [7, 21] . RV failure is the most common cause of death in PAH patients, but there is no treatment that specifically addresses RV dysfunction [17] . Despite differences in the structure and function of the RV and left ventricle (LV), it has been proposed that established treatments for LV failure may be beneficial to the failing RV in PAH [21] .
β-adrenoceptor blockers (BB) were once considered paradoxical but quickly revolutionized the treatment of LV failure by delaying ventricular remodeling and reducing mortality [6, 14] . However, concerns exist over the safety or benefit of BB in PAH [31, 34, 42] , and as such they are not recommended [17, 32] . However, PAH patients may receive BB for co-morbidities and recent small scale clinical trials have demonstrated BB safety [1, 19, 39, 40, 11] . Pre-clinical studies have shown BB are protective in animal models of PAH, by improving cardiac capillary density, reducing inflammation and fibrosis [4, 12, 33] . However, the effect of BB treatment on the function of RV myocytes from PAH animals has not been studied. The purpose of our study was therefore to investigate the mechanisms by which improvements, in response to BB treatment, may occur in the PAH myocardium. Because of the myocardial focus of our study, we chose a β 1 - selective blocker (metoprolol) as this was predicted to target the myocardium more selectively than carvedilol, which has mixed α and β adrenoceptor actions [4] or nebivolol, which has intrinsic vasodilatory pulmonary and systemic properties [33] . Metoprolol is a commonly prescribed BB which reduces mortality in LV failure [44] .We used the monocrotaline (MCT) rat model of PAH as it is well established for the study of RV failure [4, 12, 33, 3, 15, 41] . MCT rats were treated daily with metoprolol (MCT + BB) once PAH was established, to mimic the late detection and treatment that usually occurs in human PAH. Cardiac excitation contraction coupling plays a fundamental role in pump function and defective Ca 2+ handling and electrical remodeling reduce contractility and increase electrical instability in RV failure [3, 15, 41] . We tested whether actions of BB on the RV myocardium attenuated Ca 2+ handling and electrical abnormalities to facilitate enhanced RV function. Chronic treatment with metoprolol delayed the onset of RV failure signs in MCT rats, improved RV function and attenuated repolarisation remodeling in vivo. There was reduced hypertrophy of RV myocytes. Metoprolol improved the Ca 2+ handling and contractility of isolated RV myocytes from MCT rats, this was associated with preservation of transverse (t)-tubule morphology, more homogenous Ca 2+ release and decreased susceptibility to (potentially arrhythmogenic) spontaneous diastolic Ca 2+ release. These data suggest the beneficial effects of BB in PAH include actions on the mechanical and electrical activity of RV myocytes and that RV treatment may be a valid addition to PAH therapy.
Materials and methods
See online supplementary material for detailed methods. Experiments were conducted with local ethical approval in accordance with UK Home Office, European Parliament Directive 2010/63/EU guidelines on the use of animals in research.
Animal model and β-blocker treatment
A 3-group experimental design was used, as employed previously by other groups [4, 12, 33] . Male Wistar rats (200 g) received a single intraperitoneal injection of 60 mg/kg MCT to induce PAH or an equivalent volume of saline. Voluntary oral treatment with a sucrose solution (vehicle) to saline (CON) or MCT-treated (MCT) animals or with 10 mg/ kg/day metoprolol dissolved in sucrose solution (MCT + BB) was initiated 15 days post-injection when PAH was established (Table S1 ). The chosen dose was within the human equivalent dose used clinically in LV failure (see supplementary methods). MCT rats were killed by cervical dislocation, following concussion, upon showing signs of heart failure. The primary indication of heart failure was > 10 g weight loss compared to the previous day or weight loss on consecutive days, accompanied by other indicative signs including dyspnoea, piloerection, lethargy and cold extremities [18, 27, 30, 37] . CON rats were killed on the median ( ± 1) survival day of MCT rats. MCT + BB rats used for the survival study (see Fig. 1A ) were killed when heart failure signs developed. In other experiments MCT + BB rats were killed on the median ( ± 1) survival day of MCT rats unless heart failure signs occurred earlier.
In vivo monitoring
Transthoracic RV echocardiography was performed under 1.5% isoflurane anesthesia prior to the first dose of BB or sucrose only treatment on day 15, and again on the terminal day. To monitor ECGs and activity in conscious, unrestrained animals, rats were implanted with telemetric probes under anesthesia (2-3% isoflurane) using aseptic techniques. Postoperative analgesia was given by subcutaneous injection of Buprenorphine (Vetergesic 0.1 mg/kg) with the antibiotic Baytril (20 mg/kg).
Histology
10 μm thick transverse cryosections of the RV free wall were stained with fluorescein-conjugated lectin. Myocytes were manually identified in lectin-stained sections by their characteristic oval-shape when cut in cross section. The interior cell boundary of cells was manually identified and traced by an experimenter blinded to the group condition.
Single myocyte studies
Single ventricular myocytes were isolated by enzymatic digestion according to [28] The sarcolemma and t-tubule system of isolated myocytes was stained using di-8-ANEPPS (5 μmol/L) and visualized using confocal microscopy. Sodium-calcium exchange (NCX) current was recorded in discontinuous voltage clamp as the tail current at −80 mV elicited by a 20 ms depolarizing step from −80 mV to +10 mV, following 300 ms priming pulses.
Measurement of mRNA by RT-PCR and protein by Western blotting
Total RNA extraction from RV homogenates was performed using a Qiagen mini-kit. Transcript expression was normalized to the housekeeping genes 18S and GAPDH in the test samples and then made relative to the normalized signal level in the corresponding calibrator sample.
Myocardial tissue was prepared for Western blotting as described previously [15] and probed for amphiphysin II (BIN-1), junctophilin 2 (JP2), and Ca 2+ -handling proteins phospholamban (PLN) and sarco (endo)plasmic reticulum Ca 2+ ATPase 2A (SERCA) and normalized to GAPDH.
Statistics
Data are presented as mean ± s.e.m. Details of all statistical tests are given in the supplementary methods. P < .05 was considered statistically significant. The term, intermediate, is used when comparison of CON vs MCT yields a statistical difference and data mean for MCT + BB has moved towards that for CON such that MCT + BB is statistically different to neither CON nor MCT.
Results

BB delayed the onset of heart failure
The development of heart failure signs was delayed in MCT + BB rats compared with MCT rats (Fig. 1A) . Signs presented with a median of 23 days in MCT rats, whereas using the same criteria, signs presented with a median of 31 days in BB treated rats (P < .01 vs MCT). Although BB delayed the onset of heart failure, once developed, the phenotype of failing MCT and failing MCT + BB were not different.
Effect of BB treatment on RV function and electrical remodeling in vivo
The presence of PAH and RV hypertrophy and dilation in MCT treated animals, prior to BB treatment, was confirmed by in vivo echocardiography (Table S1 ). Effective sympathetic blockade by BB treatment was demonstrated by a lack of physical activity-related increase in heart rate, measured by telemetry in freely moving rats (Fig. S1 ). To assess whether BB improved RV function, CON and MCT + BB animals were studied 23 ± 1 days after a single injection of saline or MCT and compared to vehicle treated MCT rats on the day heart failure signs developed.
MCT animals displayed characteristic increases in lung:body weight RV:body weight and RV:LV + septum weights compared to CON animals (Table S2) . Echocardiography ( Fig. S2 ) revealed increased pulmonary artery pressure, RV free wall thickness and increased RV dilatation in MCT rats compared to CON (Fig. 1B , Table S3 ). MCT rats had decreased RV stroke volume (Fig. 1C , Table S3 ) and depressed cardiac output (Fig. 1D , Table S3 ). BB treatment reduced RV wall thickness and increased SV (P < .05) compared with MCT, although cardiac output was not significantly increased (P = .09, Fig. 1B-D) . A 10-15% reduction in mean RV:LV + septum ratio, pulmonary artery pressure and RV internal diameter compared to MCT animals, was not statistically significant (Table S2, Table S3 ). Lung weights were not changed by BB treatment (Table S2) .
Telemetric measurement of ECGs in conscious unrestrained animals during their inactive period on the final experimental day showed a decrease in RR interval (P < .05) and increase in QT interval (P < .001) in MCT compared with CON, both these effects were attenuated by BB treatment ( Fig. 2A, B) .
Prolongation of QT interval represents a longer repolarization and consistent with this, we observed decreased mRNA expression of genes encoding for repolarizing K + channels (I to , I K and I K1 ) in MCT compared to CON (Fig. 2C) . Expression of the Kir2.1 gene for IK 1 was decreased in MCT (P < .05) but not (P > .05) in MCT + BB. Mean mRNA expression for both Kv4.2 and Kv4.3 (responsible for I to ) were decreased in MCT and MCT + BB. Expression of mRNA for K + channel sub-units/ chaperones KChap and KChip2 was not changed but the expression of I to regulator Nfat3 was decreased in MCT (P < .05) but not (P > .05) in MCT + BB (Fig. 2D ). (Fig. 1B) , RV myocyte cross sectional area was greater in MCT than CON and MCT + BB (reduced with BB treatment by 12%, P < .05 vs MCT, Fig. 3B ). To support this observation, we also measured the geometry of single isolated RV myocytes. RV myocyte width and volume were greater in MCT cells, in comparison dimensions in MCT + BB cells were reduced by 11% and 16%, respectively (Fig. 3C  &D) . The width and volume of LV myocytes were not different between groups (Table S4) .
BB decreased RV myocyte hypertrophy
BB improve RV myocyte contractile response to increased demand
To investigate whether RV myocyte contractility was improved by BB, Ca 2+ transients and sarcomere shortening were recorded in RV myocytes paced between 1 and 7 Hz (Fig. 4A,D could impair contraction at higher frequencies and we observed decreased protein expression of the SR Ca 2+ uptake pump, SERCA in MCT rats. This was partially restored by BB treatment (P < .05 MCT vs MCT + BB, Fig. 4H ). Expression of the SERCA inhibitory protein PLN was decreased in both MCT and MCT + BB rats compared with CON (Fig. 4I ).
3.5. BB prevented t-tubule remodeling and enhanced Ca 2+ release in single RV myocytes
T-tubule structure is important for coordinated SR Ca 2+ release. Fig. 5A shows exemplar confocal images of the t-tubule system (upper panels), and following skeletonization to visualize the predominant direction of tubules (lower panels). It was apparent that tubules in CON myocytes followed a regular striated pattern in the transverse direction, whereas MCT tubules were disorganized, with more longitudinal elements. BB treatment preserved t-tubule regularity, as indicated by greater fast Fourier transform power (Fig. 5B ) and predominant Fig. 1 . Metoprolol delayed the onset of heart failure in rats with pre-existing PAH. A The median day to failure signs was increased from 23 to 31 days post MCT injection (N = 12 MCT, 15 MCT + BB rats, ** P < .01, Mantel-Cox test). Echocardiography measurements of RV function were performed on the day of heart failure signs (MCT) or the median survival day of MCT rats (CON and MCT + BB). B RV wall thickness was reduced in MCT + BB rats compared to MCT, indicating attenuation of hypertrophy. C Stroke volume was increased by BB D Cardiac output was not significantly increased with BB (P = .09 vs MCT). B-D N = 9 CON, 7 MCT, 5 MCT + BB rats. One-way ANOVA. * P < .05, *** P < .001. Fig. 2 . BB attenuated electrical remodeling. A, B N = 9-12 animal in each group, two-way ANOVA. C, D N = 10 animals in each group, oneway ANOVA. *P < .05, **P < .01, ***P < .001. One-way ANOVA. *P < .05, **P < .01, ***P < .001.
transverse orientation (Fig. 5C ). T-tubule formation and maintenance is associated with BIN-1 and junctophillin-2 (JP-2) proteins. Fig. 5D shows representative Western blots of BIN-1 and JP-2. BIN-1 expression was reduced in the RV of MCT rats compared to CON (P < .05) (Fig. 5E ). JP-2 expression was not significantly reduced in MCT compared to CON (Fig. 5F ). Fig. 5G (Fig. 6B) . The combined frequency of SCWs +WCEs (Fig. 6C ) and the proportion that were WCEs (Fig. 6D ) was decreased in MCT + BB myocytes compared with MCT myocytes (P < .05). The precursor to Ca 2+ waves are Ca 2+ sparks. Fig. 7A shows difference in group orders between blots (upper panels) and data (lower panels). H There was a reduction in protein expression of SERCA2a in MCT RV that was partially restored by BB. I There was a reduction in protein expression of PLN in the RV of MCT and MCT + BB hearts. N = 6 rats per group. B,E,H,I one-way ANOVA, C,F two-way ANOVA. *P < .05, **P < .01 vs CON, †P < .05 vs MCT + BB. exemplar line scan recordings of Ca 2+ sparks at rest (outlined in white).
The mean Ca 2+ spark frequency was greater in both MCT and MCT + BB RV cells than CON (P < .05, Fig. 7B ) without statistically significant changes in other Ca 2+ spark properties (Fig. 7 C-E) . We used a modeling approach to investigate the reasons for the differences in SCW + WCE frequency between MCT and MCT + BB myocytes. A first approximation of the likelihood of Ca 2+ wave initiation was derived according to the reported sensitivity of rat RyR open probability (Po) to cytosolic [Ca 2+ ] [25] . Fig. 7F shows simulated Ca 2+ sparks constructed from the mean values in Fig. 7C -E. The time-varying RyR P o was calculated at a distance equal to the mean resting sarcomere length of each group from the model spark centroid (white dashed line) ( Fig. 7F and Table S4 ). Fig. 7G shows that modest changes in Ca 2+ spark properties and a shorter resting sarcomere length increased peak RyR P o in MCT cells by 130% compared to CON. In contrast, the slightly decreased spark size and increased sarcomere length in MCT + BB cells increased RyR P o by only 60% compared to CON. Therefore, despite no change in Ca 2+ spark frequency, compared with MCT, this simple model predicts that the likelihood of SCW + WCE occurring should be decreased in MCT + BB cells.
A greater proportion of Ca 2+ releases were WCEs in MCT myocytes and this was decreased by BB treatment (Fig. 6D ). This effect may be related to a greater SR Ca 2+ load in MCT myocytes and a normalization of SR Ca 2+ load by BB treatment, as revealed by rapid exposure to caffeine (Fig. 8) . When subjected to the same SR loading protocol MCT myocytes generated greater (P < .05) inward NCX current than CON myocytes (Fig. S4 ). An increase in SR Ca 2+ release will generate increased inward NCX current, which may provoke Ca 2+ -induced arrhythmias (see Section 4.4).
Discussion
Here we show for the first time that β 1 -adrenoceptor blockade attenuated hypertrophy, prevented t-tubule remodeling and improved Ca 2+ handling in RV myocytes of PAH animals. These effects resulted in an improved contractile response to increased stimulation frequency and less susceptibility to potentially arrhythmic, spontaneous diastolic Ca 2+ release. We also report the novel finding that β 1 -adrenoceptor blockade attenuated repolarization abnormalities caused by PAH.
Our study was focussed upon the myocardium and for this reason ] at distances corresponding to the mean resting sarcomere length of each group (dashed line) was calculated. G The peak time-varying RyR open probability (RyR P o ) in the neighbouring junction was greatest in MCT, but was reduced by BB treatment. Data in (G) is normalised to CON. N = 5-8 rats per group, one way ANOVA. *P < .05, **P < .01.
we chose to use a β 1 -adrenoceptor blocker, the major adrenoceptor type in the myocardium. Other BBs have additional actions, e.g. carvedilol, has mixed α and β actions [4] and nebivolol has intrinsic vasodilatory pulmonary and systemic effects [33] . It is possible that these effects may be additionally beneficial in PAH, as vasodilation of the pulmonary vasculature is a central strategy in current PAH therapy.
In vivo cardiac function and electrical remodeling
The improvement in stroke volume and trend for increased cardiac output (P = .09) in MCT + BB rats occurred in the absence of significant RV afterload reduction, similar to reports using other BB [4, 12, 33] . This suggests the protective effects of metoprolol are mediated through direct actions on the myocardium, rather than secondary to pulmonary responses, and are attributable to its β 1 -selectivity. In conscious animals, metoprolol treatment did not reduce resting heart rate, but did block activity-induced increase in heart rate, this is consistent with the effect of bisoprolol reported by [12] . In conscious MCT rats, heart rate was increased compared to CON ( Fig. 2A) , conversely, under anesthesia, heart rate was decreased in MCT and MCT + BB rats (Table 3) , which is consistent with the observations of [3] . This increased sensitivity to anesthesia should be considered when interpreting cardiac output data.
In human PAH patients QT interval prolongation correlated with mortality [35] and we found BB attenuated QT prolongation. BB treatment did not cause statistically significant increases in mRNA expression of the main channels that carry I to (Kv4.2 and Kv4.3) however there was a consistent graded expression (CON > MCT + BB > MCT) of mean mRNA for Kv4.2, Kv4.3 and intermediate expression of both the I to regulator Nfatc3 [36] and the Kir2.1 channel (I K1 ). QT prolongation in MCT animals is linked to decreased expression of Kv channel mRNA, therefore our observations indicate a mechanism whereby QT prolongation may be attenuated by BB via changes in expression of several Kv channels.
Decreased RV hypertrophy with BB
Measurement of RV myocyte size and RV wall thickness by echocardiography indicated a reduction in RV hypertrophy with BB. Although the decrease in RV:body weight with BB treatment was not statistically significant the mean change (11%) was similar to the 15% decrease in myocyte size. By necessity, RV free walls were weighed following exposure to collagenase, prior to dispersion into single myocytes. Differences in the response of tissue to digestion may obscure smaller differences in RV weight between MCT and MCT + BB.
The hypertrophic response to pressure overload is considered a compensatory mechanism to normalize elevated wall stress [20] . However, blocking the hypertrophic response does not necessarily worsen outcomes in LV failure [10, 38] . Furthermore, myocardial hypertrophy is associated with increased incidence of death [26] , possibly by reducing coronary perfusion, increasing oxygen diffusion distances, or increasing energy expenditure.
BB improved the inotropic response of RV myocytes to increased demand
A definition of heart failure is the inability to cope with increased demand (e.g. the NYHA classification). In the MCT model this presents as a steeply negative contraction-frequency relationship linked to a fall in the amplitude of the Ca 2+ transient [3, 15] . Disruption of the tsystem uncouples LTCC and RyR resulting in inhomogeneities in Ca 2+ release which slow the rate of force development [13] . Loss of t-tubules in human LV failure is associated with reduced contractility of the ventricle [9] . We observed a loss of regularly spaced t-tubules in MCT. T-tubule formation and maintenance is linked to BIN-1 and JP2 [8] and in MCT myocytes we observed a reduction in BIN-1 protein, as reported in LV failure [8] , with a trend (mean CON > MCT + BB > MCT) for both BIN-1 and JP2. The downregulation of SERCA in MCT is likely to limit the ability to cycle Ca 2+ normally and this too was improved by BB. In addition we have previously shown that the contraction-frequency relationship in MCT myocytes is influenced by BB via expression of creatine kinase [15, 16] . Repolarization profile can modulate Ca 2+ handling [5] and we have shown that in MCT myocytes the stimulation frequency dependent fall in contraction is, at least in part, caused by the stimulation frequency dependent fall in action potential duration (APD) [3, 22] . Therefore, the prolonged APD WCEs are thought to be linked to delayed after depolarization (DAD) arrhythmias. Ca 2+ induced DADs are driven by inward NCX current and the greater the SR load, the greater the potential for Ca 2+ release and subsequent depolarizing NCX current (Fig. S4) . The resultant magnitude of depolarization for a given NCX current density is dependent upon resting membrane stability, which is determined largely by I K1 current carried through Kir2.1 channels [29] . We have shown that in MCT myocytes there is an increase in SR load (Fig. 8 ) and NCX current (Fig. S4 ) and have recently reported that membrane stability is decreased in these cells [22] . Thus, the decrease in WCEs in response to BB can be explained by the decrease in SR Ca 
Limitations
The MCT model is used extensively to study the effects of PAH on the RV due to the reliable induction of heart failure, although its exact mode of action is not fully understood and vascular remodeling does not lead to plexiform lesions as seen in human patients of PAH, for recent reviews of the model see [18, 27, 30, 37] . We cannot discount systemic effects of BB, however the LV, which was exposed to the same circulating levels of metoprolol as the RV, was unaffected by BB treatment (Table S4 & Fig. S3) 
Conclusions and Implications
The need to study the specific nature of RV pathophysiology has been highlighted [43] . Notwithstanding this important point, our novel observations show beneficial effects of BB on RV structural, mechanical and electrical remodelling and on intracellular Ca 2+ handling. Despite the different structure and operating environments of the RV and LV, existing treatments for LV failure may be useful adjuncts to therapies targetting pulmonary vasculature dysfunction in RV failure resulting from PAH.
Funding
This work was supported by British Heart Foundation grant [PG/ 13/3/29924].
Conflict of interest
None.
Disclosures
Some data from Fig. 1A and Table S4 have been reported in symposium paper format [16] .
